MannKind Corp
MNKD
#6449
Rank
NZ$1.31 B
Marketcap
NZ$4.26
Share price
3.38%
Change (1 day)
-51.56%
Change (1 year)

MannKind Corp (MNKD) - Net assets

Net assets on the balance sheet as of September 2025 : -NZ$77.54 Million

According to MannKind Corp's latest financial reports the company has -NZ$77.54 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MannKind Corp - Net assets on balance sheet (from 2004 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-NZ$0.14 Billion-64.1%
2023-12-31$-NZ$0.39 Billion-1.36%
2022-12-31$-NZ$0.4 Billion28.75%
2021-12-31$-NZ$0.31 Billion22.57%
2020-12-31$-NZ$0.26 Billion-11.61%
2019-12-31$-NZ$0.29 Billion8.38%
2018-12-31$-NZ$0.27 Billion-13.67%
2017-12-31$-NZ$0.31 Billion14.08%
2016-12-31$-NZ$0.27 Billion-48.22%
2015-12-31$-NZ$0.52 Billion443.66%
2014-12-31$-NZ$94.16 Million151.92%
2013-12-31$-NZ$37.38 Million-72.22%
2012-12-31$-NZ$0.14 Billion-66.52%
2011-12-31$-NZ$0.41 Billion67.11%
2010-12-31$-NZ$0.25 Billion194.95%
2009-12-31$-NZ$81.54 Million-154.55%
2008-12-31$NZ$0.14 B-68.56%
2007-12-31$NZ$0.47 B-12.68%
2006-12-31$NZ$0.54 B79.76%
2005-12-31$NZ$0.30 B43.7%
2004-12-31$NZ$0.21 B22.77%
2003-12-31$NZ$0.17 B-1.04%
2002-12-31$NZ$0.17 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
NZ$151.02 B-194,872.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$53.11 B-68,605.57%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
NZ$46.18 B-59,659.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$91.65 B-118,303.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$84.95 M-209.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$0.15 B-301.63%๐Ÿ‡บ๐Ÿ‡ธ USA